Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab.

MULTIPLE SCLEROSIS JOURNAL（2023）

引用 0|浏览9

暂无评分

摘要

ClinicalTrials.gov: NCT04847596 (https://clinicaltrials.gov/ct2/show/NCT04847596).

查看译文

关键词

COVID-19,Humoral immune response,Ofatumumab,Relapsing multiple sclerosis,SARS-CoV-2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要